Rationally Designed Short Polyisoprenol-Linked Pglb

Total Page:16

File Type:pdf, Size:1020Kb

Rationally Designed Short Polyisoprenol-Linked Pglb Communication pubs.acs.org/JACS Rationally Designed Short Polyisoprenol-Linked PglB Substrates for Engineered Polypeptide and Protein N‑Glycosylation † § † § ‡ § † Feng Liu, , Balakumar Vijayakrishnan, , Amirreza Faridmoayer, , Thomas A. Taylor, † † ‡ † Thomas B. Parsons, Goncalo̧ J.L. Bernardes, Michael Kowarik, and Benjamin G. Davis*, † Department of Chemistry, Chemistry Research Laboratory, Oxford University, Oxford OX1 3TA United Kingdom ‡ GlycoVaxyn AG, 8952 Schlieren, Switzerland *S Supporting Information ABSTRACT: The lipid carrier specificity of the protein N-glycosylation enzyme C. jejuni PglB was tested using a logical, synthetic array of natural and unnatural C10, C20, C30, and C40 polyisoprenol sugar pyrophosphates, including those bearing repeating cis-prenyl units. Unusual, short, synthetically accessible C20 prenols (nerylnerol 1d and geranylnerol 1e) were shown to be effective lipid carriers for PglB sugar substrates. Kinetic analyses for PglB revealed clear KM-only modulation with lipid chain length, thereby implicating successful in vitro application at appropriate concentrations. This was confirmed by optimized, efficient in vitro synthesis allowing >90% of Asn-linked β-N-GlcNAc-ylated peptide and proteins. This reveals a simple, flexible biocatalytic method for glycoconjugate synthesis using PglB N-glycosylation machinery and varied chemically synthesized glycosylation donor precursors. Figure 1. Bacterial N-linked glycosylation and designed unnatural candidate polyprenols 1a−g as alternative short lipid carriers for PglB- catalyzed glycosylation. The polyprenols were synthesized from building blocks 2a−d and 3a and 3b. rotein glycosylation is a vital co- or post-translational P modification that links glycans to proteins typically through N- or O- linkages. Such modifications exist widely in eukaryotic as the fact that C. jejuni PglB can be readily overexpressed in 16 and archaeal organisms and greatly expand the diversity of the functional form in Escherichia coli, highlight PglB’s potential as − proteome.1 3 While N-linked glycosylation had been believed to a synthetic biocatalyst. They suggest it as a potentially ideal be absent in prokaryotic systems, the discovery of the protein N- model from which to generate a ready synthetic system for in glycosyltransferase PglB in Gram-negative bacterium Campylo- vitro protein glycosylation. However, the donor substrates used bacter jejuni highlighted greater diversity; PglB is responsible for normally by PglB in vivo (C55 lipid pyrophosphoryl-linked − glycosylating over 50 different proteins.4 7 Since then PglB oligosaccharides containing the rare, bacterial sugar bacillos- orthologues have been found in Campylobacter lari,8 the amine (Bac)) would restrict this system (both in substrate Helicobacter genus (H. pullorum, H. canadensis, H. winghamensis)9 accessibility and product relevance). as well as Desulfovibrio desulfuricans10 and, very recently, In an attempt to optimize the PglB protein N-glycosylation Methanococcus voltae.11 In vivo PglB uses a C55 undecaprenylpyr- platform for practical, synthetic (and hence in vitro) use, we ophosphate-linked oligosaccharide as its substrate and glyco- designed an array of chemically generated polyisoprenol variants fi sylates the primary amide nitrogen of the asparagine side chain in to nd those simpler and shorter than the natural undecaprenol a D/E-X-N-X-T/S consensus sequence (where X can be any (Figure 1) and that might serve as alternative lipid carriers that amino acid except proline, Figure 1). In contrast to its eukaryotic could be recognized by PglB. Insightful prior work has elucidated fi 17,18 counterpart Stt3p, PglB does not require other proteins/subunits some aspects of the polyisoprenol speci city of PglB. and can apparently catalyze this N-glycosylation in vivo alone.12 However, estimated conversions for these reactions were ≤ Moreover, in vivo biosynthetic studies that allowed exposure of 20%. In addition, many of these prior substrates were prepared PglB to other lipid-linked oligosaccharides have suggested a enzymatically from polyisoprenols isolated from natural sources, possibly relaxed specificity toward the nature of glycan substrate, enabling only nmol analysis of lipid pyrophosphates containing as compared to the relatively highly specific eukaryotic N- the natural Campylobacter (GalNAc-GalNAc-BacdiNAc) gly- glycosylation enzymes.13 Recent elegant approaches flexibly using PglB in vivo have been developed to prepare Received: September 11, 2013 glycoproteins.14,15 These distinct characteristics of PglB, as well Published: December 16, 2013 © 2013 American Chemical Society 566 dx.doi.org/10.1021/ja409409h | J. Am. Chem. Soc. 2014, 136, 566−569 Journal of the American Chemical Society Communication a Scheme 1. Syntheses of Polyprenol Variants Scheme 2. Syntheses of Lipid-linked Oligosaccharides and use a in Glycopeptide Synthesis a(i) BuLi, THF, 1,3-dimethyl-3,4,5,6-tetrahydro-2(1H)-pyrimidinone (DMTP), −78 °C. Yield: 4a = 92%, 4b = 93%, 4c = 83%, 4d = 63%, 4e = 67%, 4f = 74%. (ii) (1) TBAF, THF, RT, 4 h; (2) LiEt3BH, ° − (dppp)PdCl2, THF, 0 C RT. Yield: 1a= 65%, 1b = 57%, 1c = 50%, 1d = 70%, 1e = 60%, 1f = 54%. cans. This revealed tantalizing activity for two shorter (mixed cis/ trans prenol-9 and prenol-8) variants. However, despite some − individual pioneering examples19 28 synthetic access to other prenols has been rare, and homologated families of lipids have not yet been probed. Therefore, with the intention of probing fuller lipid and sugar substrate plasticity and breadth in PglB and with the intention of creating synthetically accessible substrates, we first systematically varied the lipid carriers (Figure 1). As a starting point for lipid variation, we speculated that the use of repeating cis-prenyl units at the hydroxyl terminus would confer binding affinity due to a resemblance to the alcohol- terminus that bears the glycan-pyrophosphate found in the natural substrate and likely enters a binding pocket in PglB.29 This notion is supported by a crystal structure which has a Mg2+ bound at the active site.29 Subsequent modeling suggested that the lipid carrier would likely locate first in a narrow pocket that would tightly accommodate two isoprenyl units (and thus a − (i) 5a g, TBAP, TCA, DCM, RT; 5h, POCl3,Et3N, 2h. (ii) (1) CDI, impose tighter stereochemical requirements) and then along a DMF; (2) MeOH; (3) 6, DMF, RT, 3−5 days. (iii) NaOMe, MeOH. broader hydrophobic groove with potentially more relaxed Yield over 3 steps: 8a = 17%, 8b = 23%, 8c = 9%, 8d = 17%, 8e = 9%, requirements (Figure S12). Thus, compounds 1a−g, all bearing 8f = 38%, 8g = 29%, 8h = 32%, 13 = 22%, 14 = 30%. Extension one or more terminal repeating cis-prenyl units were designed reactions (blue arrows, 5−94%); see SI for further details. and synthesized as primary candidate lipid carriers (Figure 1). In brief (see SI for further details), compounds 1a−f were tri-O-acetyl-2-deoxy-α-D-glucopyranose 1-phosphate (6) using synthesized from head (compound 3a and 3b) and tail building carbonyldiimidazole (CDI)-mediated phosphoesterification.32,33 blocks (compound 2a−d). The requisite building blocks were Deacetylation with catalytic NaOMe in MeOH (Zempleń prepared and elongated using coupling between appropriate conditions) gave the lipid pyrophosphate-linked saccharides sulfones and allyl chloride. Utilization of a convergent synthetic (LPPS) 8a−g in 9−38% yield over three steps (Scheme 2). strategy in the case of long lipids (Scheme 1) allowed useful With these first synthetic LPPS’s in hand, 8a−h were then flexibility in the generation of lipids with different stereo- tested as substrates of PglB. The glycosylation of peptides chemistry. Removal of sulfonyl groups in one step using bearing the required D/E-X-N-X-S/T consensus motif was LiEt3BH/(dppp)PdCl2 valuably reduced both the total number determined by examining the increase of molecular weight of synthetic steps and the formation of isomeric products (16%/6 M urea tricine-SDS-PAGE)34 that corresponds to the resulting from double-bond migration and basic conditions.23,25 addition of GlcNAc (Figure 2). An extract from E. coli LPPS The resulting, pure synthetic polyprenols were shown to have a containing C. jejuni heptasaccharide-linked undecaprenyl d.r. (E/Z) > 95% according to the characteristic allylic methyl pyrophosphate was used as a positive control. Excitingly, 8a−e group signals in 1H NMR (see Figure S1); no unwanted isomeric were active substrates for PglB-catalyzed N-glycosylation of the product (<2%, 1H NMR signals at δ 2.7, 5.9 ppm)30 was fluorescent peptide Tamra-DANYTK as indicated by the detected. appearance of glycopeptide product bands with higher molecular These polyprenols were readily phosphorylated using mono- weight consistent with the addition of GlcNAc. This importantly (tetrabutylammonium) phosphate (TBAP) activated with revealed that the lipid carrier for the substrate of PglB can contain trichloroacetonitrile (TCA).31 We next attached just a single as few as two cis-head repeating units. The activity of 8c and 8e as residue atypical glycan to provide a stringent test of the catalytic substrates for PglB also indicated that PglB can tolerate lipid activity of PglB. Importantly, we used the sugar that would be carriers bearing trans geometry close to the hydroxyl terminus. found as the first N-linked residue in eukaryotic glycoproteins However, activity was lost as the length of lipid became shorter (but not prokaryotic and so not that normally employed by than four prenyl units: nerol (1g)-PP-GlcNAc (8g), cis,cis- Campylobacter): GlcNAc. The resulting polyprenyl mono- farnesol (1f)-PP-GlcNAc conjugate (8f), and citronellol-PP- phosphates 5a−g were therefore coupled to 2-acetamido-3,4,6- GlcNAc conjugate (8h)32,33 did not show any detectable activity 567 dx.doi.org/10.1021/ja409409h | J. Am. Chem. Soc. 2014, 136, 566−569 Journal of the American Chemical Society Communication phate (5d) with the 6-azido-GlcNAc (9) and 2-azidoGlcNAc (10, GlcNAz). These compounds would allow subsequent flexible postexpressional modifications on proteins that contain D/E-X-N-X-S/T tag via reaction of the introduced azide with a number of compatible methods.
Recommended publications
  • Glycobiology Protocols M E T H O D S I N M O L E C U L a R B I O L O G Y™
    Glycobiology Protocols M E T H O D S I N M O L E C U L A R B I O L O G Y™ John M. Walker, SERIES EDITOR 384. Capillary Electrophoresis: Methods and Protocols, 357. Cardiovascular Proteomics: Methods and Protocols, edited by Philippe Schmitt-Kopplin, 2007 edited by Fernando Vivanco, 2006 383. Cancer Genomics and Proteomics: Methods and 356. High-Content Screening: A Powerful Approach Protocols, edited by Paul B. Fisher, 2007 to Systems Cell Biology and Drug Discovery, 382. Microarrays, Second Edition: Volume 2, Applications edited by D. Lansing Taylor, Jeffrey Haskins, and Data Analysis, edited by Jang B. Rampal, 2007 and Ken Guiliano, 2007 381. Microarrays, Second Edition: Volume 1, Synthesis 355. Plant Proteomics: Methods and Protocols, edited Methods, edited by Jang B. Rampal, 2007 by Hervé Thiellement, Michel Zivy, Catherine 380. Immunological Tolerance: Methods and Protocols, Damerval, and Valerie Mechin, 2006 edited by Paul J. Fairchild, 2007 354. Plant–Pathogen Interactions: Methods and 379. Glycovirology Protocols, edited by Richard J. Protocols, edited by Pamela C. Ronald, 2006 Sugrue, 2007 353. DNA Analysis by Nonradioactive Probes: Methods 378. Monoclonal Antibodies: Methods and Protocols, and Protocols, edited by Elena Hilario and John. F. edited by Maher Albitar, 2007 MacKay, 2006 377. Microarray Data Analysis: Methods and 3352.52 Protein Engineering Protocols, edited by Kristian Applications, edited by Michael J. Korenberg, 2007 Müller and Katja Arndt, 2006 376. Linkage Disequilibrium and Association 3351.51 C. elegans: Methods and Applications, edited by Mapping: Analysis and Application, edited by Kevin Strange, 2006 Andrew R. Collins, 2007 3350.50 Protein Folding Protocols, edited by Yawen Bai 375.
    [Show full text]
  • CHEM 537: Carbohydrate Biochemistry and Glycobiology Instructor: Professor Anthony S
    CHEM 537: Carbohydrate Biochemistry and Glycobiology Instructor: Professor Anthony S. Serianni Fall 2014 8:10-9:15 AM, MWF, 322 Jordan November 14 – December 12, 2014 PART A: Monosaccharides, Oligosaccharides and Polysaccharides Textbook Biochemistry, 4th Edition, Voet/Voet, Wiley, 2011 Chapter 11: Sugars and Polysaccharides Chapter 23: Other Pathways of Carbohydrate Metabolism Supplemental Text (useful for course; on reserve in Chem/Phys Library) M. E. Taylor and K. Drickamer, Introduction to Glycobiology, 3rd Ed., Oxford, 2011 Literature Reading: Distributed electronically Topics: Aldoses and ketoses: structures, nomenclature, absolute configuration Cyclization: furanose and pyranose ring forms; anomeric configuration Anomerization (implications for saccharide binding proteins) Relative stabilities of cyclic forms Acyclic forms: aldehydo and keto forms, and their hydrates Ring conformation: conformational averaging Exocyclic conformations (C-O, N-acetyl, CH2OH) Amphiphilic character of saccharides (implications for receptor binding) Saccharide solvation: H-bonding behaviors Monosaccharide derivatives: Phosphate esters Sulfate esters Aminosugars Deoxysugars Alditols Aldonic acids (lactones) Uronic acids Dicarbonyl sugars (osones) α-ketoacids (sialic acid, KDO) Aldose-ketose isomerization (chemical, biological) Di- and oligosaccharide nomenclature Formation of glycosidic bonds: disaccharides (chemical, biological)s Mechanisms of glycoside bond formation and hydrolysis Phi/psi plots for glycosidic linkages Factors affecting linkage conformation;
    [Show full text]
  • Glycomics Hits the Big Time
    Leading Edge Essay Glycomics Hits the Big Time Gerald W. Hart1,* and Ronald J. Copeland1 1Department of Biological Chemistry, School of Medicine, Johns Hopkins University, 725 North Wolfe Street, Baltimore, MD 21205-2185, USA *Correspondence: [email protected] DOI 10.1016/j.cell.2010.11.008 Cells run on carbohydrates. Glycans, sequences of carbohydrates conjugated to proteins and lipids, are arguably the most abundant and structurally diverse class of molecules in nature. Recent advances in glycomics reveal the scope and scale of their functional roles and their impact on human disease. By analogy to the genome, transcriptome, O-GlcNAc (Hart et al., 2007). Even though Dynamic Structural Complexity or proteome, the ‘‘glycome’’ is the the generic term ‘‘glycosylation’’ is often Underlies Glycan Functions complete set of glycans and glycoconju- used to categorize and lump all glycan Glycoconjugates provide dynamic struc- gates that are made by a cell or organism modifications of proteins into one bin, tural diversity to proteins and lipids that under specific conditions. Therefore, side by side with other posttranslational is responsive to cellular phenotype, to ‘‘glycomics’’ refers to studies that attempt modifications such as phosphorylation, metabolic state, and to the developmental to define or quantify the glycome of a cell, acetylation, ubiquitination, or methylation, stage of cells. Complex glycans play crit- tissue, or organism (Bertozzi and Sasise- such a view is not only inaccurate, but ical roles in intercellular and intracellular kharan, 2009). In eukaryotes, protein also is completely misleading. If one only processes, which are fundamentally glycosylation generally involves the cova- considers the linkage of the first glycan important to the development of multicel- lent attachment of glycans to serine, to the polypeptide in both prokaryotic lularity (Figure 1).
    [Show full text]
  • Prof Benjamin G. Davis
    Prof Benjamin G. Davis Professor of Chemistry, Fellow and Tutor in Organic Chemistry, Pembroke College Ben Davis got his B.A. (1993) and D.Phil. (1996) from the University of Oxford. During this time he learnt the beauty of carbohydrate chemistry under the supervision of Professor George Fleet. He then spent 2 years as a postdoctoral fellow in the laboratory of Professor Bryan Jones at the University of Toronto, exploring protein chemistry and biocatalysis. In 1998 he returned to the U.K. to take up a lectureship at the University of Durham. In the autumn of 2001 he moved to the Dyson Perrins Laboratory, University of Oxford and received a fellowship at Pembroke College, Oxford. He was promoted to Full Professor in 2005. His group's research centres on the chemical understanding and exploitation of biomolecular function (Synthetic Biology, Chemical Biology and Chemical Medicine), with an emphasis on carbohydrates and proteins. In particular, the group's interests encompass synthesis and methodology; target biomolecule synthesis; inhibitor/probe/substrate design; biocatalysis; enzyme & biomolecule mechanism; biosynthetic pathway determination; protein engineering; drug delivery; molecular biology; structural biology; cell biology; glycobiology; molecular imaging and in vivo biology. This work has been recognised by Prizes and Awards and named Lecturerships. He sits (has sat) on the Editorial / Editorial Advisory Boards of Carbohydrate Research (2005-2012), Chemical Biology and Drug Design (2006-), Organic and Biomolecular Chemistry (2006-2011), the Biochemical Journal (Advisory Board 2002-2005, Editorial Board 2009-2016), Chemical Science (2010-2012, 2015-) and ChemBioChem (2011-). He was the Editor-in-Chief of Bioorganic Chemistry (2011-2013) and an Associate Editor of Chemical Science (2012-14).
    [Show full text]
  • SYNTHESIS Template V2.0
    Journal of Chemical Reviews, 2020, Volume 2, Issue 1, Pages 1-27 Review Article A Review on Synthesis and Applications of Statin Family Drugs as a New Generations of Anti-Blood Medicines Sajedeh Safapoor a, Hamid Yazdani b,*, Parisa Shahabi c a Department of Chemistry, Iran University of Science and Technology, Tehran, Iran b Department of Chemical Engineering, Payame Noor University, Tehran, Iran c Department of Physical Chemistry , Alzahra University, Tehran, Iran Receive Date: 28 July 2019, Revise Date: 15 September 2019, Accept Date: 15 October2019 Abstract: Cardiovascular disease (CVD) represents one of the most important health problems. One of the main risk factors for CVD death is the high cholesterol levels. Statins have been shown to lower low-density lipoprotein (LDL) cholesterol levels and the risk of cardiovascular disease, and are currently the first line of treatment for hypercholesterolemia. Atorvastatin is one of the most effective drugs and is part of the blood lipid lowering drug group. This work studies the mechanism of the use of statin family drugs and atorvastatin to determine the clinical requirements for improving the dermatology and the statins. DOI: 10.33945/SAMI/JCR.2020.1.1 Keywords: Atorvastatin, High cholesterol, Cardiovascular disease, Statins, Blood lipid lowering effect Graphical Abstract: Biography: Sajedeh Safapoor was born in Iran, (Mazandaran), in 1994. She completed her BSc (2017) degree from University of Mazandaran in pure chemistry. She is at the end of her Master’s Degree in Organic Chemistry at the University of Science and Technology where she is working on the synthesis of nanomaterials for biological & catalysis application.
    [Show full text]
  • D'alessio and Nancy M. Dahms Stigliano, Armando J. Parodi
    Glycobiology and Extracellular Matrices: Structure of the Lectin Mannose 6-Phosphate Receptor Homology (MRH) Domain of Glucosidase II, an Enzyme That Regulates Glycoprotein Folding Quality Control in the Endoplasmic Reticulum Linda J. Olson, Ramiro Orsi, Solana G. Alculumbre, Francis C. Peterson, Ivan D. Stigliano, Armando J. Parodi, Cecilia Downloaded from D'Alessio and Nancy M. Dahms J. Biol. Chem. 2013, 288:16460-16475. doi: 10.1074/jbc.M113.450239 originally published online April 22, 2013 http://www.jbc.org/ Access the most updated version of this article at doi: 10.1074/jbc.M113.450239 Find articles, minireviews, Reflections and Classics on similar topics on the JBC Affinity Sites. by Luis Ielpi on November 14, 2013 Alerts: • When this article is cited • When a correction for this article is posted Click here to choose from all of JBC's e-mail alerts This article cites 51 references, 20 of which can be accessed free at http://www.jbc.org/content/288/23/16460.full.html#ref-list-1 THE JOURNAL OF BIOLOGICAL CHEMISTRY VOL. 288, NO. 23, pp. 16460–16475, June 7, 2013 © 2013 by The American Society for Biochemistry and Molecular Biology, Inc. Published in the U.S.A. Structure of the Lectin Mannose 6-Phosphate Receptor Homology (MRH) Domain of Glucosidase II, an Enzyme That Regulates Glycoprotein Folding Quality Control in the Endoplasmic Reticulum* Received for publication, January 3, 2013, and in revised form, April 5, 2013 Published, JBC Papers in Press, April 22, 2013, DOI 10.1074/jbc.M113.450239 Linda J. Olson‡, Ramiro Orsi§, Solana G. Alculumbre§, Francis C.
    [Show full text]
  • The Bittersweet Promise of Glycobiology
    © 2001 Nature Publishing Group http://biotech.nature.com FEATURE The bittersweet promise of glycobiology Carbohydrates play a wide range of important roles in the body and, despite the challenges posed by glycobiology, are now tempting targets for drug developers. Alan Dove Although several genomes have been sequenced and many protein structures Lumen solved, there has been relatively little attention ER Golgi paid, to date, to the various ways in which pro- teins are “tweaked” through the attachment of sugars. However, the process of glycosylation is far from a decorative function. Carbohydrates help determine the three- dimensional structures of proteins, which are inherently linked to their function and their efficacy as therapeutics. Moreover, in contrast Synthesis of Glycan Trimming Further Terminal lipid-linked transfer and trimming glycosylation to some of the other chemical tags employed precursor processing by cells (e.g., phosphates and lipids), carbohy- = glucose = fucose drates exhibit a mind-boggling diversity of = mannose = galactose structures, can confer cell-type specificity, and Cytosol = N-acetylglucose = sialic acid are crucial components of cell-to-cell signal- ing. At the same time, carbohydrates make © Bob Crimi problematic drug targets; they are the most Figure 1. A simplified diagram showing the synthesis of an N-linked glycan. First, sugars are linked difficult biological molecules to analyze and onto a lipid precursor (in the cytosol), which is then flipped over into the lumen of the endoplasmic synthesize, and are rapidly broken down in the reticulum (ER) and the core oligosaccharide finished. The glycan is then transferred to the nascent, growing polypeptide. Sugars are trimmed off, and the polypeptide is then folded (grey oval) before bloodstream.
    [Show full text]
  • Dr M.R. Wormald -- Structure and Conformation of Oligosaccharides
    4th Year Biochemistry -- Glycobiology option. Dr M.R. Wormald -- Structure and conformation of oligosaccharides The lecture is based loosely on Glycoproteins: glycan presentation and protein-fold stability. M.R. Wormald and R.A. Dwek (1999) Structure, 7, R155-R160. and Conformational studies of oligosaccharides and glycopeptides: Complementarity of NMR, X-ray crystallography, and molecular modelling. M.R. Wormald, A.J. Petrescu, Y.-L. Pao, A. Glithero, T. Elliott and R.A. Dwek (2002) Chemical Reviews, published on-line, due out March 2002. and the references therein. These can be obtained from computers within the Department at http://www.bioch.ox.ac.uk/glycob/publications.html, references 324 and 432. The following are selected other references þ -- recommended and easy (at least as easy as they come) Ä -- recommended but a bit more advanced Oligosaccharide conformation/dynamics :- · General -- þ Polysaccharide shapes Rees (1977) þ Three dimensional structure of oligosaccharides explored by NMR and computer simulations Homans (1995) in “Glycoproteins”, pp.67-86, ed. Montreuil, Vligenthart and Schachter. · Computer modeling -- Computer modeling of carbohydrates: an introduction French and Brady (1990) Computer modeling of carbohydrate molecules, 1-19 Ä Computational carbohydrate chemistry: what theoretical methods can tell us Woods (1998) Glycoconjugate Journal, 15, 209-216 Oligosaccharide structures: Theory versus experiment Imberty (1997) Current Opinion In Structural Biology, 7, 617-623 · X-ray studies -- Ä A statistical analysis of N- and O-glycan linkage conformations from crystallographic data. Petrescu, et al. (1999) Glycobiology, 9, 343-352. · NMR studies -- Tertiary structure of N-linked oligosaccharides. Homans, et al. (1987) Biochemistry, 26, 6553-6560. Solution conformation of the branch points of N-linked glycans: synthetic model compounds for tri-antennary and tetra-antennary glycans Cumming, et al.
    [Show full text]
  • Principles of Glycan Recognition - Essentials of Glycobiology - NCBI Bookshelf 4/21/17, 3:52 PM
    Principles of Glycan Recognition - Essentials of Glycobiology - NCBI Bookshelf 4/21/17, 3:52 PM NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health. Varki A, Cummings RD, Esko JD, et al., editors. Essentials of Glycobiology. 2nd edition. Cold Spring Harbor (NY): Cold Spring Harbor Laboratory Press; 2009. Chapter 27 Principles of Glycan Recognition Richard D Cummings and Jeffrey D Esko. Glycans interact with many types of proteins, as exemplified by their binding to enzymes, antibodies, and glycan- binding proteins (GBPs). Binding of glycans to proteins represents the major way in which the information contained in glycan structures is recognized, deciphered, and put into biological action. This chapter describes the structural and thermodynamic principles of glycan–GBP interactions and the methods used to measure association constants. GLYCAN–PROTEIN RECOGNITION The general classes of GBPs are described in Chapter 26. GBPs differ in the types of glycans they recognize and in their binding affinity. A common question is: How does a GBP (such as a bacterial adhesin, toxin, plant lectin, viral hemagglutinin, antibody, or animal GBP) bind to only a very limited number of glycans (or even a single glycan) among the thousands that are produced by a cell? A fundamental question at the molecular level is: What forces allow a specific glycan to leave the aqueous phase to enter a protein-combining site? Understanding the molecular basis of the interaction between glycans and proteins is not merely an academic exercise in chemistry and physics, it is essential for the development of a real molecular appreciation of how glycoconjugates affect fundamental biological responses.
    [Show full text]
  • Glycobiology Solutions for Your Research and Development Needs an Esoteric Discipline?
    Glycobiology Solutions for Your Research and Development Needs An Esoteric Discipline? Glycans are nearly ubiquitous in eukaryotes and are essential for many cellular activities. However, for non-specialists, glycobiology has the reputation of being an esoteric discipline. It is among the least understood biological disciplines for several reasons including conceptual complexity and the lack of useful reagents. Our Mission Bio-Techne scientists have advanced the Glycobiology field with many peer- reviewed scientific publications. The outcome of our research and development enterprise is a broad array of solutions for your glycobiology research and development needs. Our mission is to provide useful solutions that will increase the accessibility of glycobiology research to specialists and non-specialists alike. Table of Contents What is Glycobiology? ........................................................................................................................................................................3 What is Glycosylation? .......................................................................................................................................................................3 Why is Glycosylation Important? .......................................................................................................................................................3 How Can We Help You? .....................................................................................................................................................................3
    [Show full text]
  • Binding Proteins Essentials of Glycobiology 3 Edition
    Chapter 28 Discovery and Classification of Glycan- Binding Proteins Essentials of Glycobiology 3rd edition Discovery and Classification of Glycan-Binding Proteins Glycans serve a variety of biological functions by virtue of their mass, shape, charge, and other physical properties. Many of their more specific biological roles are mediated via recognition by complementary glycan-binding proteins (GBPs). Nature has taken advantage of the diversity of glycans expressed in organisms by evolving protein modules to recognize discrete glycans that mediate specific physiological or pathological processes. This chapter provides a general classification and overview of naturally occurring GBPs, the history of their discovery, some of their biological functions and ways in which new GBPs are identified. Chapters that follow describe the analysis of glycan–protein interactions (Chapter 29), the physical principles involved (Chapter 30) and the structures and biological functions of several GBPs subclasses (Chapters 31-38). TWO DISTINCT CLASSES OF GBPs GBPs are found in all living organisms, and fall into two overarching groups – lectins and sulfated glycosaminoglycan(GAG)-binding proteins (online Appendix 28A). Lectins are further classified into evolutionarily-related families identified by “carbohydrate-recognition domains” (CRDs) based on primary amino acid and/or three-dimensional structural similarities (Figure 28.1). CRDs can exist as stand- alone proteins or as domains within larger multi-domain proteins. They typically recognize terminal groups on glycans, which fit into shallow but well-defined binding pockets (Chapters 29, 30). In contrast, proteins that bind to sulfated GAGs (heparan, chondroitin, dermatan and keratan sulfates, Chapter 17) do so via clusters of positively charged amino acids that bind specific arrangements of carboxylic acid and sulfate groups along GAG chains (Chapter 38).
    [Show full text]
  • Glycobiology and the Skin: a New Frontier Zoe Diana Draelos, MD
    CosmetiC Consultation Glycobiology and the Skin: A New Frontier Zoe Diana Draelos, MD lycobiology is a new frontier in molecular polysaccharides, such as glycogen, glycosaminoglycans, biology that is relevant to dermatology. The term and proteoglycans. Thus the various structures of glycans G was coined in 1988 by Rademacher et al1 to can be used for energy storage in the cytoplasm, can func- describe the emerging field that combined the knowledge tion as coactivators of cell-membrane receptors, can build base of carbohydrate chemistry and biochemistry with structural components of the extracellular matrix, and can cellular and molecular biology. There even is a journal enhance skin hydration. that bears the name Glycobiology. Why is glycobiology relevant to dermatology? Glycans are important in the Glycan Diversity and Glycomics structure and function of the skin and provide a new The study of glycans is extremely complex because of the target for cosmeceutical development. many types of a and b linkages that can occur between Glycobiology examines sugar chains, or glycans, that monosaccharides and other molecules. Nucleotides and are multifunctional. Many macromolecules carry a dense proteins are linear polymers that have specific linkages, array of covalently attached sugars that mediate cell-cell thus diversity of linkages is not as great. The study of and cell-matrixCOS interactions. Protein-bound glycans DERMare the 4 bases that form DNA—adenine, cytosine, guanine, found in the nucleus and cytoplasm of the cell where thymine—is known as genomics. These bases can form they function as regulatory switches. Therefore, an under- 250 four-unit structures, providing the genetic code for standing of glycobiology might provide insight on skin humans.
    [Show full text]